1. Sharawat SK, Bakhshi R,Vishnubhatla S, Bakhshi S. Mitochondrial D-loop variations in Paediatric acute myeloid leukaemia: a potential prognostic marker. Br J Haematol. 2010 May;149(3):391-8. 2. Sharawat SK, Bakhshi R,Vishnubhatla S, Gupta R, Bakhshi S. BAX/BCL2 RMFI ratio predicts better induction response in Pediatric patients with acute myeloid leukemia. Pediatr Blood Cancer. 2013 Aug;60(8):E63-66. 3. Sharawat SK, Gupta R, Raina V, Kumar L, Sharma A, Iqbal S, Bakhshi R, Vishnubhatla S, Bakhshi S. Increased coexpression of c-KIT and FLT3 receptors on myeloblasts: independent predictor of poor outcome in Pediatric acute myeloid leukemia. Cytometry B Clin Cytom. 2013 Nov-Dec;84(6):390-7. 4. Sharawat SK, Bakhshi R, Vishnubhatla S, Gupta R, Bakhshi S. FLT3-ITD mutation in relation to FLT3 expression in Pediatric AML: a prospective study from India. Pediatric Hematol Oncol. 2014 Mar;31(2):131-7. 5. Sharawat SK, Raina V, Kumar L, Sharma A, Bakhshi R, Vishnubhatla S, Gupta R, Bakhshi S. Quantitative assessment of BAX transcript and flow cytometric expression in acute myeloid leukemia: a prospective study. Hematology. 2014 Oct;19(7):404-11. 6. Sharawat SK, Vishnubhatla S, Bakhshi R, Raina V, Kumar L, Sharma A, Bakhshi S. Relative receptor tyrosine kinases and anti-apoptotic transcripts hold potential for predicting inferior outcome in adult acute myeloid leukemia: a prospective pilot study. Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):501-508. 7. Sharawat SK, Bakhshi R,Vishnubhatla S, Bakhshi S. High receptor tyrosine kinase (FLT3, KIT) transcript versus anti-apoptotic (BCL2) transcript ratio independently predicts inferior outcome in pediatric acute myeloid leukemia. Blood Cells Mol Dis. 2015 Jan;54(1):56-64. 8. Sharawat SK, Raina V, Kumar L, Sharma A, Bakhshi R,Vishnubhatla S, Gupta R, Bakhshi S. High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in FLT3 internal tandem duplication (ITD) negative patients in adult acute myeloid leukaemia : A prospective pilot study from India. Indian J Med Res. 2016 May;143(Supplement):S11-S16. 9. Tyagi A, Pramanik R, Vishnubhatla S, Ali S, Bakhshi R, Chopra A, Singh A, Bakhshi S. Pattern of mitochondrial D-loop variations and their relation with mitochondrial encoded genes in pediatric acute myeloid leukemia. Mutat Res. 2018 Jul;810:13-18. 10. Tyagi A, Pramanik R, Vishnubhatla S, Bakhshi R, Bakhshi S. Prognostic impact of mitochondrial DNA D-loop variations in pediatric acute myeloid leukemia.Oncotarget. 2019 Feb 12;10(13):1334-1343. 11. Tyagi A, Pramanik R, Bakhshi R,Vishnubhatla S, Bakhshi S. Apoptosis: A biomarker of high- risk phenotype in pediatric acute myeloid leukemia? Int J Lab Hematol. 2019 Feb;41(1):141- 147. 12. Tyagi A, Pramanik R, Bakhshi R, Singh A, Vishnubhatla S, Bakhshi S. Expression of mitochondrial genes predicts survival 13. Tyagi A, Pramanik R, Bakhshi R,Vishnubhatla S, Bakhshi S. Genetic Landscape of Mitochondrial Regulatory Region in Pediatric Acute Myeloid Leukemia: Changes from Diagnosis to Relapse. J Pediatr Genet. 2019 Dec;8(4):193-197. 14. Maan K, Tyagi R, Dutta A, Bakhshi R, Rana P. Comparative metabolic profiles of total and partial body radiation exposure in mice using an untargeted 15. Chaudhary S, Ganguly S, Palanichamy JK, Singh A, Bakhshi R, Jain A, Chopra A, Bakhshi S. PGC1A driven enhanced mitochondrial DNA copy number predicts outcome in pediatric acute myeloid leukemia. Mitochondrion. 2021 May;58:246-254. 16. Chaudhary S, Ganguly S, Singh A, Palanichamy JK, Chopra A, Bakhshi R,Bakhshi S. Mitochondrial complex II and V activity is enhanced in pediatric acute myeloid leukemia. Am J Blood Res. 2021 Oct 15;11(5):534-543. 17. Maan K, Baghel R, Bakhshi R, Dhariwal S, Tyagi R, Rana P. An integrative chemometric approach and correlative metabolite networking of LC-MS and NMR based urine metabolomics for radiation signatures. Mol Omics. 2022 Mar 28;18(3):214-225. 18. Chaudhary S, Ganguly S, Singh A, Palanichamy JK, Bakhshi R, Chopra A, Bakhshi S. Mitochondrial biogenesis gene POLG correlates with outcome in pediatric acute myeloid leukemia. Leuk Lymphoma. 2022 Apr;63(4):1005-1008. 19. Kumari K, Singh KS, Singh K, Bakhshi R, Singh LR. TMAO to the rescue of pathogenic protein variants. Biochim Biophys Acta Gen Subj. 2022 Nov;1866(11):130214. 20. Chaudhary S, Ganguly S, Palanichamy JK, Singh A, Pradhan D, Bakhshi R, Chopra A, Bakhshi S. Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients. Front Oncol. 2023 Feb 9;13:1109518 |